Home | Contact us | Site map | Careers | Q&A | Advantages of Québec |
 Search
| 
 NEWS:
  SGF Profile  
  Investment Groups  
  Our Investments  
  Documentation Center  
 
Our Groups
 | 
Agri-Food
 | 
Mines, Materials, Energy, Environment
 | 
Forest Products
 | 
Technologies and Life Sciences
 | 
|
|
 | 
|
|
  
 

Group's Investments

Priority Sectors 

Investment Criteria 

Group's Investments 

Links 

Contact us 

 

 

Principal investments:
Life Sciences
  SGF's
Participation
  Shareholder(s)
Aeterna Zentaris 
Development of medication to fight cancer and other diseases
 

17%

  SGF
Solidarity Fund QFL, Other
Axcan Pharma Inc.
Development and production of prescription products in the field of gastroenterology

N/A 

SGF
TPG Capital
Other

Atrium Innovations  
Production and distribution of dietary supplements and health products

6%

SGF 
Aeterna Laboratories inc.
Solidarity Fund QFL
Private Investor
Fonds d’investissement bioalimentaire
Biotechnologies Océanova 
Production of active ingredients obtained from the St-Lawrence marine biomass

31%

SGF 
Atrium,
Bio-Innovation, Solidarity Fund QFL
GeneChem Thérapeutiques
Venture capital fund specialized in research projects and companies involved in genomics
 

7%

  SGF
Fonds Bombardier, Shire Pharmaceutical, Solidarity Fund QFL
MédiaMed Technologies
Innovative technological solutions and consulting services used by hospitals and health care and social services centres.

46%

SGF
Médicago 

Manufacturing of recombinant proteins for pharmaceutical use

 

8%

  SGF
Other
Génopole Premier jour
Investment Fund
 

6% 

  SGF
CDC Entreprises, Groupe Industriel Marcel Dassault, FSTQ

Warnex
Specialized analytical, bioanalytical and medical laboratory services

 

25%

  SGF
Public


Home  |  Legal Notice  |  Corporate Policies  | 

 Copyright © SGF 2008